Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson’s disease: study protocol for the ISTRA ADJUST PD randomized, controlled study

MLA

Taku Hatano, et al. “Evaluating the Impact of Adjunctive Istradefylline on the Cumulative Dose of Levodopa-Containing Medications in Parkinson’s Disease: Study Protocol for the ISTRA ADJUST PD Randomized, Controlled Study.” BMC Neurology, vol. 22, no. 1, Mar. 2022, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12883-022-02600-w.

APA

Taku Hatano, Osamu Kano, Renpei Sengoku, Asako Yoritaka, Keisuke Suzuki, Noriko Nishikawa, Yohei Mukai, Kyoichi Nomura, Norihito Yoshida, Morinobu Seki, Miho Kawabe Matsukawa, Hiroo Terashi, Katsuo Kimura, Jun Tashiro, Shigeki Hirano, Hidetomo Murakami, Hideto Joki, Tsuyoshi Uchiyama, Hideki Shimura, … Hiroshi Nagayama. (2022). Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson’s disease: study protocol for the ISTRA ADJUST PD randomized, controlled study. BMC Neurology, 22(1), 1–9. https://doi.org/10.1186/s12883-022-02600-w

Chicago

Taku Hatano, Osamu Kano, Renpei Sengoku, Asako Yoritaka, Keisuke Suzuki, Noriko Nishikawa, Yohei Mukai, et al. 2022. “Evaluating the Impact of Adjunctive Istradefylline on the Cumulative Dose of Levodopa-Containing Medications in Parkinson’s Disease: Study Protocol for the ISTRA ADJUST PD Randomized, Controlled Study.” BMC Neurology 22 (1): 1–9. doi:10.1186/s12883-022-02600-w.